Structural evolution of SARS-CoV-2 omicron in human receptor recognition.

Wei Zhang1,2 Ke Shi3 Qibin Geng1,2 Morgan Herbst1,2 Michael Wang1,2 Linfen Huang1,2 Fan Bu1,2 Bin Liu4 Hideki Aihara3 Fang Li1,2
Affiliations 4 institutions
  1. Department of Pharmacology, University of Minnesota Medical School , Minneapolis, Minnesota, USA.
  2. Center for Coronavirus Research, University of Minnesota , Minneapolis, Minnesota, USA.
  3. Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota , Minneapolis, Minnesota, USA.
  4. Hormel Institute, University of Minnesota , Austin, Minnesota, USA.

Abstract

Understanding the evolutionary strategies of the SARS-CoV-2 omicron variant is crucial for comprehending the COVID-19 pandemic and preventing future coronavirus pandemics. In this study, we determined the crystal structures of the receptor-binding domains (RBDs) from currently circulating omicron subvariants XBB.1 and XBB.1.5 (also the emerging XBB.1.9.1), each complexed with human ACE2. We studied how individual RBD residues evolved structurally in omicron subvariants, specifically how they adapted to human ACE2. Our findings revealed that residues 493 and 496, which exhibited good human ACE2 adaptation in pre-omicron variants, evolved to poor adaptation in early omicron subvariants (but with good adaption to mouse ACE2) and then reverted to good adaptation in recent omicron subvariants. This result is consistent with the hypothesis that non-human animals facilitated the evolution of early omicron subvariants. Additionally, residue 486, which exhibited good human ACE2 adaptation in early omicron subvariants, evolved to poor adaptation in later omicron subvariants and then returned to good adaptation in recent omicron subvariants. This result is consistent with the hypothesis that immune evasion facilitated the evolution of later omicron subvariants. Thus, our study suggests that both non-human animals and immune evasion may have contributed to driving omicron evolution at different stages of the pandemic. IMPORTANCE The sudden emergence and continued evolution of the SARS-CoV-2 omicron variant have left many mysteries unanswered, such as the origin of early omicron subvariants and the factors driving omicron evolution. To address these questions, we studied the crystal structures of human ACE2-bound receptor-binding domains (RBDs) from omicron subvariants XBB.1 and XBB.1.5 (XBB.1.9.1). Our in-depth structural analysis sheds light on how specific RBD mutations adapt to either human or mouse ACE2 and suggests non-human animals and immune evasion may have influenced omicron evolution during different stages of the pandemic. These findings provide valuable insights into the mechanisms underlying omicron evolution, deepen our understanding of the COVID-19 pandemic, and have significant implications for preventing future coronavirus pandemics.

Supporting text Virus Host Location
angiotensin-converting enzyme 2 179 COVID-19 467 omicron subvariants 1 receptor-binding domain (RBD) 4 receptor-binding motif (RBM) 1 surface plasmon resonance 6 X-ray crystallography 5 Evolution, Molecular 176 SARS-CoV-2 453 Spike Glycoprotein, Coronavirus 274 Angiotensin-Converting Enzyme 2 177 Animals 1948 Humans 1440 Mice 253 Mutation 209 SARS-CoV-2 variants 86 ACE2 protein, human 87 spike protein, SARS-CoV-2 157

Evidence records

4 total
Functional Mechanism
3 records · 2 evidence types
Evidence type
1 records
OVE7246
Key finding

Crystal structures demonstrated that the receptor-binding domains of SARS-CoV-2 Omicron subvariants XBB.1, XBB.1.5, and XBB.1.9.1 bind human ACE2, confirming usage of the human ACE2 receptor for entry.

Virus
Host
Location
Not specified
Supporting text

We determined the crystal structures of the receptor-binding domains (RBDs) from currently circulating omicron subvariants XBB.1 and XBB.1.5 (also the emerging XBB.1.9.1), each complexed with human ACE2.

Method
crystal structure determination | structural analysis of receptor-binding domain complex
Receptors
human ACE2
Evidence type
2 records
OVE7247
Key finding

Residues 493 and 496 in the SARS-CoV-2 omicron RBD show host-specific structural adaptation, shifting from efficient human ACE2 binding to mouse-adapted binding and later reverting to improved human ACE2 adaptation.

Virus
Host
Not specified
Location
Not specified
Supporting text

Residues 493 and 496, which exhibited good human ACE2 adaptation in pre-omicron variants, evolved to poor adaptation in early omicron subvariants (but with good adaption to mouse ACE2) and then reverted to good adaptation in recent omicron subvariants.

Genes or proteins
Spike receptor-binding domain (RBD)
Receptors
human ACE2 | mouse ACE2
Mutations
Residue 493 | Residue 496
Mechanism types
receptor binding | host-range expansion
OVE7248
Key finding

Residue 486 in the SARS-CoV-2 omicron RBD underwent structural changes affecting human ACE2 binding, consistent with immune evasion-driven adaptation in later omicron subvariants.

Virus
Host
Not specified
Location
Not specified
Supporting text

Residue 486, which exhibited good human ACE2 adaptation in early omicron subvariants, evolved to poor adaptation in later omicron subvariants and then returned to good adaptation in recent omicron subvariants.

Genes or proteins
Spike receptor-binding domain (RBD)
Receptors
human ACE2
Mutations
Residue 486
Mechanism types
receptor binding | immune escape
Genomic Evolution
1 records · 1 evidence types
Evidence type
1 records
OVE7249
Key finding

Structural and evolutionary analyses indicate that both non-human animals and immune evasion processes contributed to the evolution of SARS-CoV-2 omicron subvariants at different pandemic stages.

Virus
Host
Location
Not specified
Supporting text

Our study suggests that both non-human animals and immune evasion may have contributed to driving omicron evolution at different stages of the pandemic.

Genes or proteins
receptor-binding domain (RBD) | ACE2
Analysis methods
structural analysis | comparative evolutionary analysis